1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine
- $44 - $1487
- Product name: 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine
- CAS: 85405-03-4
- MF: C28H58NO7P
- MW: 551.736381
- EINECS:
- MDL Number:MFCD02259312
- Synonyms:1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine;1-O-HEXADECYL-2-BUTYRYL-SN-GLYCERO-3-PHOSPHOCHOLINE;C16-04:0 PC;(R)-2-(Butyryloxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate
5 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- 50mg
- ManufacturerAK Scientific
- Product number1297AH
- Product description1-o-Hexadecyl-2-butyryl-Sn-glycero-3-phosphocholine
- Packaging5mg
- Price$313
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number60928
- Product descriptionButanoyl PAF ≥98%
- Packaging1mg
- Price$44
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number60928
- Product descriptionButanoyl PAF ≥98%
- Packaging5mg
- Price$193
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number60928
- Product descriptionButanoyl PAF ≥98%
- Packaging10mg
- Price$341
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number60928
- Product descriptionButanoyl PAF ≥98%
- Packaging50mg
- Price$1487
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1297AH | 1-o-Hexadecyl-2-butyryl-Sn-glycero-3-phosphocholine | 5mg | $313 | 2021-12-16 | Buy |
Cayman Chemical | 60928 | Butanoyl PAF ≥98% | 1mg | $44 | 2024-03-01 | Buy |
Cayman Chemical | 60928 | Butanoyl PAF ≥98% | 5mg | $193 | 2024-03-01 | Buy |
Cayman Chemical | 60928 | Butanoyl PAF ≥98% | 10mg | $341 | 2024-03-01 | Buy |
Cayman Chemical | 60928 | Butanoyl PAF ≥98% | 50mg | $1487 | 2024-03-01 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMF: 14 mg/ml; DMSO: 12 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 5 mg/ml
solubility :DMF: 14 mg/ml; DMSO: 12 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 5 mg/ml
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which promote the differentiation of monocytes and activate polymorphonuclear leukocytes. One of these substances was recently isolated and purified from oxLDL, and identified as azelaoyl PC. Butanoyl PAF is a closely related compound which retains at least 10% of the agonist potency of platelet-activating factor (PAF) itself. Further, butanoyl PAF is present in oxLDL in amounts more than 100 times greater than enzymatically generated PAF. Butanoyl PAF is therefore one of the important signalling molecules present in oxLDL.Suppliers and manufacturers
Creative Enzymes
Codow Chemical Co.,Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Chengdu Dianchun Technology Co., Ltd
Shanghai Hongye Biotechnology Co. Ltd
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
MedBioPharmaceutical Technology Inc
Shanghai Haohong Scientific Co., Ltd.
TargetMol Chemicals Inc.
Hubei Danding Pharmaceutical Technology Co., Ltd